It was found that IL-1β was able to upregulate the chemoresistance-associated gene, the tumor protein 63 (TP63) isoform ∆NP63α, contributing to the acquisition of cisplatin resistance in breast cancer cells [160]. The gene discussed is IL1B; the disease is breast cancer.